Markets

n\nICoreConnect, incorporated Receives Endorsement for Cloud ePrescribing Software by Illinois State Dental Society\n\nICoreConnect, incorporated (NASDAQ:ICCT) has once again proven its position as a leader in the healthcare industry with its latest endorsement from the Illinois State Dental Society (ISDS). The company’s cloud-based software and technology, specifically its cloud ePrescribing software, iCoreRx, has received an endorsement from the ISDS, marking the 23rd state dental or medical association to do so. This endorsement highlights the effectiveness of iCoreRx in streamlining the prescription process for doctors.\n\nThe ISDS endorsement is significant as it represents over 60% of state dental and medical associations in the U.S. That now endorse iCoreConnect products. This further solidifies the company’s position as a leader in increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform.\n\nRobert McDermott, President and CEO of iCoreConnect, expressed his excitement about the partnership with ISDS, stating, “Illinois is a new state endorsement for us. We’re thrilled to partner with such a great state organization. The Illinois State Dental Society works diligently to bring its members quality options that will help them work more effectively and produce greater business results. We’re eager for their member dentists to experience a better way of prescription writing that takes just a few fast, accurate, and compliant steps.”\n\nThis endorsement comes at a crucial time as Illinois controlled substance prescribers, including dentists, will be required to prescribe electronically for more than 150 schedule II-V controlled substances in a calendar year starting January 1, 2024. This new law makes iCoreRx an essential tool for healthcare professionals in Illinois.\n\nChristopher Larsen, DDS, ISDS Member Services Committee Chair, commented on the partnership, saying, “ISDS is excited to partner with iCoreConnect to offer our Membership a seamless and affordable solution to meet the requirements of the upcoming ePrescribing law through iCoreRx. All endorsed partners are rigorously vetted by the ISDS Member Services Committee. ICoreRx stood out from competitors due to its ability to integrate with almost any practice management software and ease of use, all at an affordable price.”\n\nICoreConnect, incorporated is a market-leading company known for its innovation in solving healthcare business problems. The company’s platform of 16 SaaS enterprise solutions and more than 100 product endorsements with state or regional healthcare associations across the United States highlights its commitment to customer feedback and responding to the market’s needs.’

n\nICoreConnect, incorporated Receives Endorsement for Cloud ePrescribing Software by Illinois State Dental Society\n\nICoreConnect, incorporated (NASDAQ:ICCT) has once again proven its position as a leader in the healthcare industry with its latest endorsement from the Illinois State Dental Society (ISDS). The company’s cloud-based software and technology, specifically its cloud ePrescribing software, iCoreRx, has received an endorsement from the ISDS, marking the 23rd state dental or medical association to do so. This endorsement highlights the effectiveness of iCoreRx in streamlining the prescription process for doctors.\n\nThe ISDS endorsement is significant as it represents over 60% of state dental and medical associations in the U.S. That now endorse iCoreConnect products. This further solidifies the company’s position as a leader in increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform.\n\nRobert McDermott, President and CEO of iCoreConnect, expressed his excitement about the partnership with ISDS, stating, “Illinois is a new state endorsement for us. We’re thrilled to partner with such a great state organization. The Illinois State Dental Society works diligently to bring its members quality options that will help them work more effectively and produce greater business results. We’re eager for their member dentists to experience a better way of prescription writing that takes just a few fast, accurate, and compliant steps.”\n\nThis endorsement comes at a crucial time as Illinois controlled substance prescribers, including dentists, will be required to prescribe electronically for more than 150 schedule II-V controlled substances in a calendar year starting January 1, 2024. This new law makes iCoreRx an essential tool for healthcare professionals in Illinois.\n\nChristopher Larsen, DDS, ISDS Member Services Committee Chair, commented on the partnership, saying, “ISDS is excited to partner with iCoreConnect to offer our Membership a seamless and affordable solution to meet the requirements of the upcoming ePrescribing law through iCoreRx. All endorsed partners are rigorously vetted by the ISDS Member Services Committee. ICoreRx stood out from competitors due to its ability to integrate with almost any practice management software and ease of use, all at an affordable price.”\n\nICoreConnect, incorporated is a market-leading company known for its innovation in solving healthcare business problems. The company’s platform of 16 SaaS enterprise solutions and more than 100 product endorsements with state or regional healthcare associations across the United States highlights its commitment to customer feedback and responding to the market’s needs.’$ICCT2023-12-20T17:41:58.402Z

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button